CN102491300B - 一种双亲性单分散羟基磷灰石单晶纳米棒的制备方法 - Google Patents
一种双亲性单分散羟基磷灰石单晶纳米棒的制备方法 Download PDFInfo
- Publication number
- CN102491300B CN102491300B CN201110363123.8A CN201110363123A CN102491300B CN 102491300 B CN102491300 B CN 102491300B CN 201110363123 A CN201110363123 A CN 201110363123A CN 102491300 B CN102491300 B CN 102491300B
- Authority
- CN
- China
- Prior art keywords
- monodisperse
- amphiphilic
- hydroxyapatite
- nanorod
- monocrystal nanorod
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229910052588 hydroxylapatite Inorganic materials 0.000 title claims abstract description 57
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 title claims abstract description 56
- 239000002073 nanorod Substances 0.000 title claims abstract description 38
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 238000000034 method Methods 0.000 claims abstract description 38
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 28
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims abstract description 11
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims abstract description 11
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims abstract description 11
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000005642 Oleic acid Substances 0.000 claims abstract description 11
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims abstract description 11
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims abstract description 11
- 238000006243 chemical reaction Methods 0.000 claims abstract description 8
- 239000000126 substance Substances 0.000 claims abstract description 6
- 229910019142 PO4 Inorganic materials 0.000 claims abstract description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims abstract description 5
- 239000010452 phosphate Substances 0.000 claims abstract description 5
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims abstract description 3
- 239000012752 auxiliary agent Substances 0.000 claims abstract description 3
- ZCCIPPOKBCJFDN-UHFFFAOYSA-N calcium nitrate Chemical compound [Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ZCCIPPOKBCJFDN-UHFFFAOYSA-N 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 239000007864 aqueous solution Substances 0.000 claims description 11
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 10
- 239000011575 calcium Substances 0.000 claims description 9
- 239000013543 active substance Substances 0.000 claims description 7
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 6
- 230000015572 biosynthetic process Effects 0.000 claims description 6
- 229910052791 calcium Inorganic materials 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- 238000003786 synthesis reaction Methods 0.000 claims description 6
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 5
- 239000000243 solution Substances 0.000 claims description 5
- 239000012046 mixed solvent Substances 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 239000001488 sodium phosphate Substances 0.000 claims description 4
- 229910000162 sodium phosphate Inorganic materials 0.000 claims description 4
- 235000011008 sodium phosphates Nutrition 0.000 claims description 4
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims description 4
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 3
- 229910000397 disodium phosphate Inorganic materials 0.000 claims description 3
- 235000019800 disodium phosphate Nutrition 0.000 claims description 3
- 239000007791 liquid phase Substances 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 2
- 239000000470 constituent Substances 0.000 claims description 2
- 239000008367 deionised water Substances 0.000 claims description 2
- 229910021641 deionized water Inorganic materials 0.000 claims description 2
- 229940045641 monobasic sodium phosphate Drugs 0.000 claims description 2
- 150000003016 phosphoric acids Chemical class 0.000 claims description 2
- 239000011574 phosphorus Substances 0.000 claims description 2
- 229910052698 phosphorus Inorganic materials 0.000 claims description 2
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims description 2
- 210000000988 bone and bone Anatomy 0.000 abstract description 14
- 239000000463 material Substances 0.000 abstract description 14
- 239000002994 raw material Substances 0.000 abstract description 6
- 239000002639 bone cement Substances 0.000 abstract description 4
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 abstract description 3
- 238000000576 coating method Methods 0.000 abstract description 2
- 239000002105 nanoparticle Substances 0.000 abstract description 2
- 230000035484 reaction time Effects 0.000 abstract description 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 abstract 1
- 159000000007 calcium salts Chemical class 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
- 230000002194 synthesizing effect Effects 0.000 abstract 1
- 229960000935 dehydrated alcohol Drugs 0.000 description 8
- 239000000047 product Substances 0.000 description 7
- 238000001027 hydrothermal synthesis Methods 0.000 description 6
- 230000005540 biological transmission Effects 0.000 description 4
- 229960004756 ethanol Drugs 0.000 description 4
- 238000007789 sealing Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical group FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 description 4
- 230000007547 defect Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000001338 self-assembly Methods 0.000 description 2
- 238000009736 wetting Methods 0.000 description 2
- 208000018084 Bone neoplasm Diseases 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 241000370738 Chlorion Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 239000001116 FEMA 4028 Substances 0.000 description 1
- 208000035126 Facies Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-L Phosphate ion(2-) Chemical compound OP([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-L 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 229910052586 apatite Inorganic materials 0.000 description 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 1
- 229960004853 betadex Drugs 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000000593 microemulsion method Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000011858 nanopowder Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000004819 osteoinduction Effects 0.000 description 1
- 230000002138 osteoinductive effect Effects 0.000 description 1
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000000634 powder X-ray diffraction Methods 0.000 description 1
- 239000012716 precipitator Substances 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000003980 solgel method Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000012876 topography Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110363123.8A CN102491300B (zh) | 2011-11-16 | 2011-11-16 | 一种双亲性单分散羟基磷灰石单晶纳米棒的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110363123.8A CN102491300B (zh) | 2011-11-16 | 2011-11-16 | 一种双亲性单分散羟基磷灰石单晶纳米棒的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102491300A CN102491300A (zh) | 2012-06-13 |
CN102491300B true CN102491300B (zh) | 2014-09-03 |
Family
ID=46183171
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110363123.8A Active CN102491300B (zh) | 2011-11-16 | 2011-11-16 | 一种双亲性单分散羟基磷灰石单晶纳米棒的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102491300B (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6325446B2 (ja) | 2012-09-18 | 2018-05-16 | 株式会社小糸製作所 | 吸着方法およびドラッグデリバリー用担持体 |
CN105129756B (zh) * | 2015-09-22 | 2019-10-25 | 西北大学 | 一种低温矿化制备亚纳米级羟基磷灰石超细针的方法 |
CN106063947A (zh) * | 2016-05-25 | 2016-11-02 | 西北大学 | 一种硒掺杂纳米羟基磷灰石的制备方法 |
CN108046227A (zh) * | 2017-12-21 | 2018-05-18 | 衢州学院 | 一种低温制备微米级针状羟基钙磷灰石的方法 |
CN109502565A (zh) * | 2018-12-21 | 2019-03-22 | 湖北工业大学 | 一步法制备油溶性羟基磷灰石纳米棒的方法 |
CN113398326B (zh) * | 2021-05-21 | 2022-07-26 | 华南理工大学 | 一种表面接枝egcg的羟基磷灰石纳米棒及其制备方法和应用 |
CN116374973A (zh) * | 2023-02-08 | 2023-07-04 | 浙江大学 | 一种双层油酸法制备水相均匀分散的羟基磷灰石的方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101297978A (zh) * | 2008-06-17 | 2008-11-05 | 东南大学 | 一种羟基磷灰石纳米杆的制备方法 |
-
2011
- 2011-11-16 CN CN201110363123.8A patent/CN102491300B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101297978A (zh) * | 2008-06-17 | 2008-11-05 | 东南大学 | 一种羟基磷灰石纳米杆的制备方法 |
Non-Patent Citations (2)
Title |
---|
以环糊精为模板水热合成羟基磷灰石;朱丹琛等;《人工晶体学报》;20100228;第39卷(第1期);第214-220页 * |
朱丹琛等.以环糊精为模板水热合成羟基磷灰石.《人工晶体学报》.2010,第39卷(第1期),第214-220页. |
Also Published As
Publication number | Publication date |
---|---|
CN102491300A (zh) | 2012-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102491300B (zh) | 一种双亲性单分散羟基磷灰石单晶纳米棒的制备方法 | |
Hou et al. | Calcium phosphate-based biomaterials for bone repair | |
Singh et al. | Customized hydroxyapatites for bone-tissue engineering and drug delivery applications: A review | |
Zhou et al. | Monetite, an important calcium phosphate compound–Its synthesis, properties and applications in orthopedics | |
Murugan et al. | Production of ultra-fine bioresorbable carbonated hydroxyapatite | |
Ghosh et al. | Self-setting calcium phosphate cements with tunable antibiotic release rates for advanced antimicrobial applications | |
Dorozhkin | Nanodimensional and nanocrystalline apatites and other calcium orthophosphates in biomedical engineering, biology and medicine | |
Andrés et al. | Manipulation of Mg2+–Ca2+ switch on the development of bone mimetic hydroxyapatite | |
In et al. | On the crystallization of hydroxyapatite under hydrothermal conditions: Role of sebacic acid as an additive | |
Sonoda et al. | Influence of emulsion on crystal growth of hydroxyapatite | |
CN101518659B (zh) | 一种生物活性仿生磷酸钙纳米材料及其制备方法和用途 | |
Li et al. | Controllable synthesis of biomimetic hydroxyapatite nanorods with high osteogenic bioactivity | |
WO2011016772A1 (en) | Ion substituted calcium phosphate particles | |
CN105358189A (zh) | 仿生胶原-羟基磷灰石复合材料 | |
Saxena et al. | Hydroxyapatite: an inorganic ceramic for biomedical applications | |
Zhu et al. | Deformable biomaterials based on ultralong hydroxyapatite nanowires | |
CN102079514A (zh) | 一种羟基磷灰石纳米晶的制备方法 | |
Jariya et al. | Drug delivery and antimicrobial studies of chitosan-alginate based hydroxyapatite bioscaffolds formed by the Casein micelle assisted synthesis | |
Prasad et al. | Surfactant-assisted synthesis of hydroxyapatite particles: A comprehensive review | |
Zhang et al. | Physicochemical and cytological properties of poorly crystalline calcium-deficient hydroxyapatite with different Ca/P ratios | |
Zhou et al. | Synthesis of poly hydroxypropyl methacrylate cryogel incorporated with Zn/Ce substituted hydroxyapatite nanoparticles for rejuvenation of femoral fracture treatment in a rat model | |
CN1693415B (zh) | 近红外荧光量子点标记的羟基磷灰石及其制备方法和应用 | |
Chai et al. | Fabrication of phospholipid vesicle-interacted calcium phosphate films with sterilization stability | |
Ali et al. | SrO assisted 1393 glass scaffold with enhanced biological compatibility | |
CN106620843A (zh) | 一种具有生物活性和抑菌性的复合骨水泥及制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation method of amphiphilic monodisperse hydroxyapatite monocrystal nanorod Effective date of registration: 20161010 Granted publication date: 20140903 Pledgee: Xi'an high tech emerging industry investment fund partnership (limited partnership) Pledgor: Shaanxi Giant Biogene Technology Co., Ltd. Registration number: 2016610000043 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20180312 Granted publication date: 20140903 Pledgee: Xi'an high tech emerging industry investment fund partnership (limited partnership) Pledgor: Shaanxi Giant Biogene Technology Co., Ltd. Registration number: 2016610000043 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PP01 | Preservation of patent right |
Effective date of registration: 20191008 Granted publication date: 20140903 |
|
PP01 | Preservation of patent right | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20200106 Granted publication date: 20140903 |
|
PD01 | Discharge of preservation of patent |